The results show that GQD can significantly decrease the serum levels of IFN-β, TNF-α, and MDA in NAFLD rats and increase the expressions of IL-2, SOD, and GSH-Px. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.